Glisson B S, Smallwood S E, Ross W E
Biochim Biophys Acta. 1984 Oct 5;783(1):74-9. doi: 10.1016/0167-4781(84)90080-0.
Based on the observation that VP-16-induced DNA damage can be demonstrated in isolated nuclei but not in purified DNA, and that this effect is temperature-dependent, it is postulated that the mechanism of action of VP-16 involves an essential intranuclear event, perhaps enzyme-mediated, which is a prerequisite for the cleavage of DNA. Using alkaline elution to assay single-strand breaks in isolated L1210 nuclei, we have further characterized conditions influencing this putative intranuclear reaction. We have found drug activity to be dependent on magnesium and pH and to be stimulated by low concentrations of ATP (0.05-1 mM), an effect which was not observed with a nonhydrolyzable analog of ATP. Heat-labile activity in a nuclear non-histone protein extract was critical to VP-16-mediated DNA damage. This new evidence lends further credence to the hypothesis that activity of an intranuclear enzyme, possessing characteristics consistent with a type II DNA topoisomerase, is a prerequisite for the cleavage of DNA by VP-16.
VP - 16诱导的DNA损伤可在分离的细胞核中得到证实,但在纯化的DNA中却不能,并且这种效应是温度依赖性的,因此推测VP - 16的作用机制涉及一个必不可少的核内事件,可能是酶介导的,这是DNA切割的一个先决条件。使用碱性洗脱法检测分离的L1210细胞核中的单链断裂,我们进一步确定了影响这种假定的核内反应的条件。我们发现药物活性依赖于镁和pH值,并受到低浓度ATP(0.05 - 1 mM)的刺激,而ATP的不可水解类似物则未观察到这种效应。核非组蛋白提取物中的热不稳定活性对于VP - 16介导的DNA损伤至关重要。这一新证据进一步支持了以下假设:具有与II型DNA拓扑异构酶一致特征的核内酶的活性是VP - 16切割DNA的先决条件。